Cited by 74Pituitary Gland Disorders and TreatmentsBone health and osteoporosis researchGrowth Hormone and Insulin-like Growth Factors

Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function

Bolanowski, Marek, Daroszewski, Jacek, Mędraś, Marek, Zadrożna-Śliwka, Beata·2005·Journal of Bone and Mineral Metabolism

Abstract

Acromegaly is a rare disease caused by growth hormone (GH) hypersecretion. GH and insulin-like growth factor-I (IGF-I) exert anabolic activity in bones. Nevertheless, bone mineral density (BMD) loss is not uncommon in patients with acromegaly. It is assumed to be due to hypogonadism associated with the acromegaly. The aim of the study was to examine BMD at various skeletal sites and bone turnover and to assess the influence of impaired gonadal function and disease activity on BMD and turnover changes in acromegaly. A total of 62 patients were studied (40 women, 22 men). Among the women, 22 had active disease and 18 were cured; 16 women had normal gonadal function, and 24 were hypogonadal. Altogether, 12 men presented with active acromegaly, and 10 were cured; normal gonadal function was found in 10 men, and hypogonadism was diagnosed in 12 men. Controls were 30 healthy subjects. Densitometry using dual-energy X-ray absorptiometry of the lumbar spine, proximal femur, forearm, and total body was carried out. Bone turnover was studied based on serum osteocalcin, C-terminal collagen type 1 crosslinks, and bone alkaline phosphatase concentration. A disadvantageous effect of acromegaly on bone density was associated with hypogonadism in the distal radius (in women), the proximal femur (in men), and the total body (both sexes). An anabolic effect of GH during active acromegaly was present in the proximal femur only in men. We confirmed increased bone turnover in the presence of acro…

Integrity signals

Registry

Crossref · 10.1007/s00774-005-0649-9

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Indicators of bone resorption such as urinary hydroxyproline/creatinine, urinary type I collagen cross-linked N-telopeptide, and serum C-terminal collagen type I cross-links are in higher concentrations in acromegaly than in controls.

    “Indicators of bone resorption such as urinary hydroxyproline/creatinine, urinary type I collagen cross-linked N-telopeptide, and serum C-terminal collagen type I cross-links are in higher concentrations than in controls [28, 29, 35, 40, 43].”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [43]

  • Osteocalcin, a specific marker of bone formation, is elevated in subjects with active acromegaly.

    “A specific marker of bone formation, osteocalcin, is elevated in subjects with active disease [28, 29, 35, 40, 43].”

    From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [43]

The citation lists haven’t been fetched yet

References 25 · Cited by 74

Authors
Bolanowski, M., Daroszewski, J., Mędraś, M., & Zadrożna-Śliwka, B.
Affiliations
Wroclaw Medical University (PL)
Corresponding author
Bolanowski, Marek
Venue
Journal of Bone and Mineral Metabolism
Published
2005-12-27
Volume
24
Issue
1
Pages
72-78
ISSN
  • 0914-8779 (ISSN-L)
  • 1435-5604
OpenAlex
W2005618591
Cited by
74
References
25
Citations by year
2025: 1 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 6 · 2020: 5 · 2019: 1 · 2018: 6 · 2017: 2 · 2016: 4 · 2015: 9 · 2014: 6 · 2013: 5 · 2012: 5
FWCI
1.03
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Bone and Mineral Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
acromegaly, bone mineral density, bone turnover, hypogonadism, gonadal function, growth hormone, insulin-like growth factor I, sex differences, disease activity, osteocalcin, C-terminal telopeptide, bone-specific alkaline phosphatase, proximal femur, distal radius, bone loss
MeSH terms
Acromegaly, Adult, Aged, Alkaline Phosphatase, Female, Gonads, Humans, Hypogonadism, Insulin-Like Growth Factor I, Male, Middle Aged, Absorptiometry, Photon, Bone Density, Osteocalcin, Bone Remodeling, Human Growth Hormone, Collagen Type I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review